case_images: PMC11068447_01
case_images: Total scores of PTSD Checklist for DSM-5 during 1 week of mifepristone treatment, preceded by 2 weeks of baseline and followed by 2 weeks postintervention for the three cases. The dots represent the scores, and the horizontal lines represent the period-based mean.
case_images: CRIPS2024-4768647.002.jpg
case_images: PMC11068447_04_CRIPS2024-4768647.002.jpg
case_images: fig2
case_images: Upon visual inspection, it was observed that Matthew's PCL-5 scores were somewhat lower during the week he used mifepristone and notably lower during the postintervention phase than during the baseline phase (Figure 2, bottom).
case_images: PMC11068447_02
case_images: PMC11068447_03
case_images: Total scores of PTSD Checklist for DSM-5 during 1 week of mifepristone treatment, preceded by 2 weeks of baseline and followed by 2 weeks postintervention for the three cases. The dots represent the scores, and the horizontal lines represent the period-based mean.
case_images: CRIPS2024-4768647.002.jpg
case_images: PMC11068447_04_CRIPS2024-4768647.002.jpg
case_images: fig2
case_images: Upon visual inspection, it was observed that Matthew's PCL-5 scores were somewhat lower during the week he used mifepristone and notably lower during the postintervention phase than during the baseline phase (Figure 2, bottom).
case_images: PMC11068447_04
case_images: Total scores of PTSD Checklist for DSM-5 during 1 week of mifepristone treatment, preceded by 2 weeks of baseline and followed by 2 weeks postintervention for the three cases. The dots represent the scores, and the horizontal lines represent the period-based mean.
case_images: CRIPS2024-4768647.002.jpg
case_images: PMC11068447_04_CRIPS2024-4768647.002.jpg
case_images: fig2
case_images: Upon visual inspection, it was observed that Matthew's PCL-5 scores were somewhat lower during the week he used mifepristone and notably lower during the postintervention phase than during the baseline phase (Figure 2, bottom).
case_images: PMC11068447_05